Marché des services de tests bioanalytiques en Afrique – Tendances et prévisions de l’industrie jusqu’en 2029

Market Analysis and Insights

The rising focus on the analytical testing of biologics and biosimilar has enhanced the market's demand. The increasing healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increasing preference for outsourcing analytical testing also contributes to the rising demand for bioanalytical testing services in the region.

The Africa bioanalytical testing services market is growing in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market. The increasing demand for specialized bioanalytical testing services further boosts the market growth. However, the shortage of skilled professionals and pricing pressure faced by the major players might hamper the development of the Africa bioanalytical testing services market in the forecast period.

The rising healthcare expenditure and strategic initiatives by market players are giving opportunities to the market to enhance. However, innovative formulations demanding a unique bioanalytical testing approach and the growing need to improve the sensitivity of bioanalytical methods are key challenges for market growth.

Data Bridge Market Research shows that the Africa bioanalytical testing services market will grow at a CAGR of 6.8% from 2022 to 2029.

Market Definition

Bioanalytical testing is the quantitative determination of drugs and/or metabolites in biological matrices such as blood, serum, plasma, or urine, tissue, and skin samples specifically applied to toxicology, pharmacology, bioequivalence, pharmacokinetics, and bioavailability studies in animals or humans. Bioanalytical services are provided to researchers by contract research organizations with the resources, expertise, instrumentation, and technology to tackle the most complex programs across multiple modalities and therapeutic areas for clinical and preclinical bioanalysis.

Bioanalytical Testing Services Market Dynamics

Drivers

• Rise in focus on the analytical testing of biologics and biosimilar

Biologics represent one of the most promising new therapeutic areas and are becoming increasingly important in the pharmaceutical market; around 800 products are in the pipeline. One of the key reasons for this is the rising prevalence of chronic diseases.

According to the Biomed Central article in May 2020, it is reported that Africa faces a double burden of infectious and chronic diseases. Age-specific mortality rates from chronic diseases are higher in sub-Saharan Africa than in virtually all other regions, both men and women. Over the next ten years, the continent is projected to experience the most significant increase in death rates from cardiovascular disease, cancer, respiratory disease, and diabetes

The expected rise in biosimilar R&D will bring a growing demand for the associated bioanalytical testing services—compatibility studies for biosimilar, stability testing, product release testing, and protein analysis of biosimilar—to reduce the risks associated with drug development. Moreover, the introduction of biosimilar and the move toward continuous processing create the need for more rapid and sensitive analytical techniques.

• Increase in preference for outsourcing analytical testing

The outsourcing of bioanalytical testing services supports pharmaceutical companies lessen risks by avoiding significant funds in purchasing analytical equipment and maintaining the workforce, mainly when development efforts are in the initial stages. The accessibility of specialized analytical testing service providers with critical capabilities to deliver optimal results rapidly has led to growing consideration among pharmaceutical businesses to outsource testing services to third-party service providers.

Hence, the Increasing preference for outsourcing analytical testing is expected to drive the market in the forecasted period.

Opportunity

• Rising adoption of the quality by design approach

A rising number of conferences, symposia, workshops, and training courses, especially in emerging countries, have played a crucial role in creating awareness about the benefits of adopting the QbD approach among pharmaceutical and biopharmaceutical manufacturers and research organizations.

The increasing acceptance and adoption of the QbD approach among pharmaceutical and biopharmaceutical companies across the region are expected to play a key role in the growth of the bioanalytical testing services market in the coming years.

Restraint/Challenge

• Dearth of skilled professionals

The shortage of skilled professionals to handle advanced equipment required for bioanalytical tests is a significant factor that is expected to restrain the growth of this market. In the African countries as there is less awareness among people to work in such industry and acquire specific skills related to this field

For instance,

As per the World Economic Forum article in September 2019, it is observed that the current lack of skills has real consequences. Of the CEOs highly concerned about the availability of key skills, 65% of African CEOs said the skills shortage prevented them from innovating effectively. In comparison, 59% conceded that their quality standards and customer experience were being undermined. In addition, 54% confirmed that they were missing their growth targets because of inadequate skills

This may hamper the adoption of new technologies and methodologies, thereby limiting the growth of the bioanalytical testing services market in the coming years.

Post-COVID-19 Impact on Africa Bioanalytical Testing Services Market

COVID-19 has negatively affected the market. Lockdowns and isolations during pandemics complicate clinical trials. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

• In January 2022, SGS SA announced that the company had collaborated Microsoft. The collaboration has integrated Microsoft's cross-industry expertise, advanced data solutions and productivity platforms, and the global network and leading industry competence to develop innovative solutions for the Testing, Inspection and Certification (TIC) industry's customers. This will help the company to increase its global presence and make strong foot-prints in the market

Africa Bioanalytical Testing Services Market Scope

Africa bioanalytical testing services market is categorized into two notable segments, such as type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Bioanalytical Services For Preclinical And Clinical Studies
• Small Molecule Bioanalytical Services
• Large Molecule Bioanalytical Services

Based on type, the Africa bioanalytical testing services market is segmented into bioanalytical services for preclinical and clinical studies, small molecule bioanalytical services and large molecule bioanalytical services.

End User

• Clinical Research Organization
• Pharmaceutical And Biotechnology Companies
• Hospitals Labs
• Instituts universitaires et de recherche
• Autres

En fonction de l’utilisateur final, le marché africain des services de tests bioanalytiques est segmenté en organisations de recherche clinique, sociétés pharmaceutiques et biotechnologiques, laboratoires hospitaliers, instituts universitaires et de recherche et autres.

Analyse/perspectives régionales du marché des services de tests bioanalytiques

Le marché des services de tests bioanalytiques est analysé et des informations sur la taille du marché et les tendances sont fournies par type et utilisateur final, comme référencé ci-dessus.

Les pays couverts dans le rapport sur le marché des services de tests bioanalytiques sont l’Afrique du Sud, le Nigéria, l’Angola, l’Éthiopie et le reste de l’Afrique.

Le marché des services de tests bioanalytiques en Afrique devrait croître en raison des dépenses croissantes en R&D dans l'industrie pharmaceutique et biopharmaceutique. En outre, une préférence accrue pour l'externalisation des tests analytiques dans la région stimulera davantage la croissance du marché au cours de la période de prévision.

L'Afrique du Sud devrait dominer le marché africain des services de tests bioanalytiques en termes de part de marché et de chiffre d'affaires. Elle continuera à accroître sa domination au cours de la période de prévision. Cela est dû à la forte demande de services bioanalytiques.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays et les tarifs d'importation et d'exportation, sont quelques-uns des indicateurs importants utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques africaines, les défis auxquels elles sont confrontées en raison de la forte concurrence des marques locales et nationales et l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché des services de tests bioanalytiques

Le paysage concurrentiel du marché des services de tests bioanalytiques fournit des détails par concurrent. Les détails comprennent un aperçu de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence européenne, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché des services de tests bioanalytiques.

Certains acteurs majeurs du marché des services de tests bioanalytiques en Afrique sont FARMOVS (PTY) LTD, SGS SA, Labcorp, Synexa Life Sciences BV, Q2 Solutions., Medpace, BARC SOUTH AFRICA, Merieux NutriSciences Corporation, entre autres.

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse de la part de marché Afrique VS. Région et fournisseur. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.

SKU-68811